Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease

By Crane Andrew T.   Rossignol Julien   Dunbar Gary L.  

Brain Sciences, Vol. 4, Iss. 1, 2014-03 ,pp. : 202-219

MDPI

Access to resources Recommend Favorite

Neuropsychiatric Burden in Huntington’s Disease

By Paoli Ricardo Augusto   Botturi Andrea   Ciammola Andrea   Silani Vincenzo   Prunas Cecilia   Lucchiari Claudio   Zugno Elisa   Caletti Elisabetta  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

Ca2+ handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 134, Iss. 4, 2015-08 ,pp. : 652-667

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the ubiquitin-proteasome system impaired in Huntington’s disease?

By Ortega Z.   Díaz-Hernández M.   Lucas J.  

Cellular and Molecular Life Sciences CMLS, Vol. 64, Iss. 17, 2007-09 ,pp. : 2245-2257

Springer Publishing Company

Access to resources Recommend Favorite

Challenges of Huntington's disease and quest for therapeutic biomarkers

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 1-2, 2015-02 ,pp. : 147-158

John Wiley & Sons Inc

Access to resources Recommend Favorite